Myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) Clinical Trials
Conditions / Myelin oligodendrocyte glycoprotein antibody-associated disease (mogad)
Delta Trials records 1 clinical trial for Myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) in its publicly accessible dataset. From the full dataset, 1 actively seeking eligible participants and 0 trials have reached completion. This research is conducted across 73 study locations around the world. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
1
Total Trials
1
Recruiting
0
Completed
0
Other Active
0
Terminated since 2020
73
Study Locations
Browse by location (73 total)
- São Paulo, Brazil 1 trialAll trials in São Paulo, Brazil
- Fukushima, Japan 1 trialAll trials in Fukushima, Japan
- Zabrze, Poland 1 trialAll trials in Zabrze, Poland
- Rome, Italy 1 trialAll trials in Rome, Italy
- St Leonards, Australia 1 trialAll trials in St Leonards, Australia
- Box Hill, Australia 1 trialAll trials in Box Hill, Australia
- Washington D.c., United States 1 trialAll trials in Washington D.c., United States
- Katowice, Poland 1 trialAll trials in Katowice, Poland
- Catania, Italy 1 trialAll trials in Catania, Italy
- Verona, Italy 1 trialAll trials in Verona, Italy
- Houston, United States 1 trialAll trials in Houston, United States
- Birmingham, United States 1 trialAll trials in Birmingham, United States
- Berlin, Germany 1 trialAll trials in Berlin, Germany
- Columbus, United States 1 trialAll trials in Columbus, United States
- Fukuoka, Japan 1 trialAll trials in Fukuoka, Japan
- Datteln, Germany 1 trialAll trials in Datteln, Germany
- Chiba, Japan 1 trialAll trials in Chiba, Japan
- Kanagawa, Japan 1 trialAll trials in Kanagawa, Japan
- Düsseldorf, Germany 1 trialAll trials in Düsseldorf, Germany
- Savannah, United States 1 trialAll trials in Savannah, United States